Photo

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Tornado chasers

Storm chasers brave danger and debris as they try to capture photos of tornadoes' destructive power.  Slideshow 

Photo

Running while blind

Blind or visually impaired students compete in blind track and field tournament.  Slideshow 

Sponsored Links

DNA egg swap prevents rare diseases in babies

Related Topics

Sharon Bernardi, 44, with her son Edward, 20, who suffers from Leigh's disease, a form of mitochondrial disease. REUTERS/Newcastle University/Handout

Sharon Bernardi, 44, with her son Edward, 20, who suffers from Leigh's disease, a form of mitochondrial disease.

Credit: Reuters/Newcastle University/Handout

LONDON | Wed Apr 14, 2010 4:31pm EDT

LONDON (Reuters) - British scientists have mastered a controversial technique using cloning technology to prevent some incurable inherited diseases by swapping DNA between two fertilized human eggs.

Lead researcher Doug Turnbull of Newcastle University said on Wednesday he hoped the first babies free from so-called mitochondrial diseases would be born within three years.

But applying the technique in the clinic, to help women at risk of passing on the disorders, will require a change in British law that currently bans reproduction from such manipulated embryos, which would end up having three biological parents.

Around one in 6,500 children are born with serious diseases caused by malfunctioning mitochondrial DNA, leading to a range of conditions that can include fatal heart problems, liver failure, brain disorders, blindness and muscular weakness.

The Newcastle team's technique effectively replaces mitochondria, which act as tiny energy-generating batteries inside cells, so a baby doesn't inherit faults from its mother. Mitochondria are only passed down the maternal line.

"What we've done is like changing the battery on a laptop. The energy supply now works properly, but none of the information on the hard drive has been changed," Turnbull said.

"A child born using this method would have correctly functioning mitochondria, but in every other respect would get all their genetic information from their father and mother."

The researchers use a variation of the same technique used to make Dolly the cloned sheep in 1996.

Within a day of uniting egg and sperm using in vitro fertilization, nuclear DNA is removed from the embryo and implanted into a donor egg, whose own nucleus has been removed and discarded.

TWO OR THREE PARENTS?

The resulting embryo inherits nuclear DNA, or genes, from both its parents but mitochondrial DNA from a second "mother" who donated the healthy egg. In humans, about 37 genes are found in the mitochondria -- the rest of the more than 20,000 known genes are in the DNA found in the nucleus.

For critics like Josephine Quintavalle of campaign group Comment on Reproductive Ethics that makes it "a step too far in meddling with the building blocks of human life."

"No matter how small the contribution from the egg of the donor woman, the fact remains that an attempt is being made to create a three-parent child," she said.

But Alison Murdoch of the Newcastle Fertility Center, whose patients donated eggs used in the studies, told reporters such criticisms ignored the fact that all the characteristics of the baby would come from its two real parents.

Researchers in Newcastle first disclosed two years ago they had created a handful of embryos with swapped DNA, but it is only now that the process has been shown to produce viable embryos.

Writing in the journal Nature, the team said 80 embryos were created and developed in the laboratory for six to eight days to reach the blastocyst stage, comprising a ball of around 100 cells. They were then destroyed, in line with current rules.

(Editing by Tim Pearce)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (4)
JWMGEO wrote:
I don’t understand why insuring against a terrible disease should be called going “a step too far”.

Apr 14, 2010 2:18pm EDT  --  Report as abuse
jennbarry wrote:
You would understand if you were educated in molecular biology. I find this article alarming, and I have only a very limited understanding of molecular biology.

Apr 14, 2010 3:20pm EDT  --  Report as abuse
wrote:
Those who are opposed to this approach are making a big deal out of nothing. The mitochondria in our cells are organelles responsible for providing the bulk of our energy requirements and they assist in some other cell processes as well. It’s the cell organelle responsible for using the oxygen we breathe.

Mitochondrial DNA codes for several of the proteins that play a role in creating energy out of the food that we eat. It doesn’t determine any of our physical characteristics. And most important of all, mitocondrial DNA isn’t unique to any one individual. Total strangers can have the same identical mitochondrial DNA if they have a common female ancestor several generations in the past.

It seems to me that too many of us have this notion that our DNA is significantly different from everyone else’s, simply because we have different physical features. That’s not how it works. In reality, you can take any two people born anywhere in the world and from any ‘race’ and they’ll still have only 1% difference between the DNA. The other thing that people need to realize is that the bulk of our DNA codes for proteins that have nothing to do with the way we look. Most of our DNA controls how our bodies works, not what our bodies looks like.

Apr 14, 2010 7:10pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.